Yannic Danger
Impact in
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis
- IL-33, ST2, and ILC Pathways
- T-cell and B-cell Immunology
- Dermatology top 5%
- Dermatology and Skin Diseases
Papers in
- Immunology 10
- T-cell and B-cell Immunology 4
- Immune Cell Function and Interaction 4
- Co-authors
- Hugues Gascan (7 shared papers)Sylvie Chevalier (6 shared papers)Elisa Ravon (3 shared papers)Emilie Vénéreau (2 shared papers)Laurence Preisser (2 shared papers)Jean‐Pierre Molès (1 shared paper)Soufiane Ghannam (1 shared paper)Hans Yssel (1 shared paper)
In The Last Decade
Yannic Danger
18 papers receiving 953 citations
Peers
Comparison fields: 5 of 83
- Immunology 487
- Dermatology 118
- Genetics 104
- Immunology and Allergy 49
- Orthopedics and Sports Medicine 58
Countries citing papers authored by Yannic Danger
This map shows the geographic impact of Yannic Danger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yannic Danger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yannic Danger more than expected).
Fields of papers citing papers by Yannic Danger
This network shows the impact of papers produced by Yannic Danger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yannic Danger. The network helps show where Yannic Danger may publish in the future.
Co-authors
The 25 scholars most cited alongside Yannic Danger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 429 | |
| 2 | 2012 | 393 | |
| 3 | 2015 | 24 | |
| 4 | 2010 | 20 | |
| 5 | 2009 | 17 | |
| 6 | 2015 | 16 | |
| 7 | 2005 | 10 | |
| 8 | 2015 | 10 | |
| 9 | 2020 | 7 | |
| 10 | 2015 | 7 | |
| 11 | 2021 | 7 | |
| 12 | 2004 | 6 | |
| 13 | 2022 | 6 | |
| 14 | 2019 | 6 | |
| 15 | 2012 | 6 | |
| 16 | 2024 | 3 | |
| 17 | Design of cocaethylene and cocaine conjugates to produce highly selective polyclonal antibodies. | 2006 | 2 |
| 18 | 2018 | 2 | |
| 19 | 2025 | 0 |
About Yannic Danger
Yannic Danger is a scholar working on Immunology, Molecular Biology, Oncology, Toxicology and Hematology, having authored 19 papers that have together received 971 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (4 papers), T-cell and B-cell Immunology (4 papers), Immune Cell Function and Interaction (4 papers), Blood groups and transfusion (3 papers), Forensic Toxicology and Drug Analysis (3 papers), Platelet Disorders and Treatments (3 papers), Psychedelics and Drug Studies (2 papers) and Dermatology and Skin Diseases (2 papers). The work is most often cited by research in Immunology (487 citations), Dermatology (118 citations), Genetics (104 citations), Immunology and Allergy (49 citations) and Orthopedics and Sports Medicine (58 citations). Yannic Danger has collaborated with scholars based in France, Canada and Mali. Frequent co-authors include Hugues Gascan, Sylvie Chevalier, Elisa Ravon, Emilie Vénéreau, Laurence Preisser, Jean‐Pierre Molès, Soufiane Ghannam, Hans Yssel, Jérôme Pène and Frédéric Blanchard. Their work appears in journals such as Transfusion, Journal of Biological Chemistry, iScience, Scientific Reports and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.